Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist

Prof. Dr. Eduardo Vignoto Fernandes | Medicine and Health Sciences | Research Excellence Award

Federal University of Jataí | Brazil

Prof. Dr. Eduardo Vignoto Fernandes, is a distinguished researcher in immunometabolism, human physiology, and applied health sciences, recognized for his multidisciplinary contributions integrating experimental pathology, human anatomy, and exercise science. With 28 Scopus-indexed publications, 119 citations, and an h-index of 5, his research advances understanding of metabolic, genetic, and physiological adaptations in healthy individuals and those with clinical or lifestyle-related conditions, including people living with HIV/AIDS. Fernandes has produced influential studies covering immunometabolism responses, exercise physiology, body composition, sports nutrition, metabolic syndrome, cancer immunopathology, and antiretroviral therapy effectiveness. His scientific output includes peer-reviewed articles, systematic reviews, and collaborative investigations published in respected journals such as Metabolites, Geriatrics, Sports, Current HIV Research, Molecular Biology Reports, and Discover Public Health. Fernandes leads and collaborates on research projects exploring exercise prescription, photo biomodulation, osteopathic interventions, muscle damage biomarkers, and functional health indicators such as handgrip strength. His expertise also extends to educational research on human anatomy, including remote versus in-person instruction and academic performance in health-science students. Through public health outreach initiatives, he contributes to community wellness by developing structured exercise programs and participating in One Health–aligned interdisciplinary actions. Supported by competitive funding from major Brazilian agencies, he conducts R&D focused on immunometabolism health, functional performance, and applied health interventions. His growing citation base, broad research themes, and sustained collaborations underscore his scientific relevance and expanding impact across exercise science, pathology, and applied health research.

Profiles: Scopus | Google Scholar | ORCID | ResearchGate

Featured Publications

1. De Rossi, T., Lozovoy, M. A. B., da Silva, R. V., Fernandes, E. V., Geraldino, T. H., & others. (2011). Interações entre Candida albicans e hospedeiro. Semina: Ciências Biológicas e da Saúde, 32(1), 15–28.

2. Weber, M. G., Dias, S. S., de Angelis, T. R., Fernandes, E. V., Bernardes, A. G., & others. (2021). The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: A systematic review and meta-analysis. Amino Acids, 53(11), 1663–1678.

3. Romanin, P., Palermo, R. L., Cavalini, J. F., Favaro, L. S., De Paula-Petroli, S. B., Fernandes, E. V., & others. (2019). Multidrug- and extensively drug-resistant Acinetobacter baumannii in a tertiary hospital from Brazil: The importance of carbapenemase encoding genes and related resistance mechanisms. Microbial Drug Resistance, 25(9), 1365–1373.

4. Khan, S. A., Venancio, E. J., Ono, M. A., Fernandes, E. V., Hirooka, E. Y., Shimizu, C. F., & others. (2019). Effects of subcutaneous ochratoxin-A exposure on immune system of broiler chicks. Toxins, 11(5), 264.

5. Vitorino, R. W. S., Fornaziero, C. C., & Fernandes, E. V. (2020). Evaluation of performance and perception of learning in teaching human anatomy: Traditional method vs constructivist method. International Journal of Morphology, 38(1), 74–77.

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Yan Bai | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Yan Bai | Medicine and Health Sciences | Best Researcher Award

Yunnan University | China

Dr. Yan Bai is a highly accomplished postdoctoral researcher at the State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan and the Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming, China. She earned her PhD in Cell Biology from Yunnan University, MSc in Pharmacology from the Chinese PLA Medical Academy, and BSc in Pharmacy from Dali University, establishing a strong interdisciplinary foundation spanning pharmacology, microbiology, and cellular biology. Prior to her current role, she conducted research at the Chinese PLA General Hospital, focusing on combination therapies against multidrug-resistant bacteria. Her research primarily investigates mitochondrial homeostasis, tumor biology, and the molecular mechanisms underlying mitochondrial genetic diseases, with particular attention to mitochondria-associated condensates (MATOs) as regulators of protein translation and mitochondrial integrity. Dr. Yan Bai has led and contributed to several major research projects, including grants from the National Natural Science Foundation of China, the National Basic Research Program, and Yunnan Province Science and Technology initiatives. Her work has resulted in high-impact publications in journals such as Nature Aging (2025), Sci China Life Sci (2025), EMBO J (2024), and Biophys Rep (2024). According to Scopus, she has authored 10 publications, cited 177 times across 169 documents, with an h-index of 6, demonstrating both productivity and influence in her field. Through her interdisciplinary collaborations, innovative experimental approaches, and groundbreaking findings on mitochondrial regulation and aging, Dr. Yan Bai has made significant contributions to biomedical science, advancing understanding of mitochondrial biology, disease mechanisms, and translational biomedical applications.

Profile: Scopus

Featured Publications

Bai, Y., Ma, T., Zhao, S., Li, S., Wang, X., Li, J., Sun, W., Yang, Y., Liu, F., Shan, Q., Qin, Z., Liu, N., Zhang, J., Tian, F., Duan, M., Chen, S., Lai, F., Chen, Q., Wu, X., & Yang, C. (2025). Mitochondria-associated condensates maintain mitochondrial homeostasis and promote lifespan. Nature Aging.

Hao, Q., Bai, Y., Guan, R., Dong, R., Bai, W., Hamdy, H., Wang, L., Meng, M., Sun, Y., Shen, J., & Sun, J. (2025). VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis. Science China Life Sciences, 68(7), 1996–2009.

Hao, Q., Dong, R., Bai, W., Chang, D., Yao, X., Zhang, Y., Xu, H., Li, H., Kui, X., Wang, F., Wang, Y., Wang, C., Lei, Y., Chen, Y., Shen, J., Sang, L., Bai, Y., & Sun, J. (2024). Screening for metastasis-related genes in mouse melanoma cells through sequential tail vein injection. Biophysical Reports, 10(1), 15–21.

Liu, F., Li, T., Gong, H., Tian, F., Bai, Y., Wang, H., Yang, C., Li, Y., Guo, F., Liu, S., & Chen, Q. (2024). Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23. EMBO Journal, 43(17), 3787–3806.

Wang, T., Zhou, X., Bai, Y., Zhang, L., Li, L., & Wu, C. (2018). Antiepileptic effect of uridine may be caused by regulating dopamine release and receptor expression in corpus striatum. Brain Research, 1688, 47–53.

Bai, Y., Liu, B., Wang, T., Cai, Y., Liang, B., Wang, R., Liu, Y., & Wang, J. (2015). In vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 59(3), 1466–1471.

Liu, B., Bai, Y., Liu, Y., Di, X., Zhang, X., Wang, R., & Wang, J. (2015). In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. Journal of Chemotherapy, 27(5), 271–276.

Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Andrej Sirek | Medicine and Health Sciences | Best Researcher Award

University Hospital Basel | Switzerland

Dr. Andrej Sirek is a dedicated Pathology Resident at the University Hospital Basel, Institute of Medical Genetics and Pathology, where he is actively shaping his career at the intersection of clinical diagnostics and medical research. With his educational foundation built in leading European institutions, Dr. Andrej Sirek has developed a strong grounding in medical genetics, histopathology, and laboratory sciences, which now supports his dual role as both clinician and researcher. His residency provides him with exposure to complex pathology cases while also allowing him to engage in research that seeks to bridge genetic profiling and diagnostic pathology, with the long-term aim of contributing to precision medicine and early disease detection. Currently, he has completed one research project and is progressing with another, both expected to yield indexed publications in the near future. Despite being at an early stage of his academic career, his commitment to innovation in pathology has already been recognized with a nomination for the Best Researcher Award. He maintains active membership in several professional organizations, including SGPATH, ÖGPATH, SGZ, and ESP, which strengthens his global collaborations and engagement with the wider pathology community. While he has yet to publish peer-reviewed articles, his ongoing research demonstrates his potential to make impactful contributions to the field. His academic and professional journey underscores the promise of a new generation of clinician-scientists who integrate advanced diagnostic techniques with research innovation to improve patient care. Dr. Andrej Sirek’s trajectory highlights his dedication, scholarly potential, and commitment to excellence in pathology and medical genetics.

Profile: ORCID

Featured Publications

Dr. Andrej Sirek has contributed to impactful research in pathology, focusing on diagnostic innovations, tumor biology, and clinicopathological correlations. Key recent publications include:

Sirek, A., Hench, I. B., Hench, J., Alborelli, I., Gross, M. W., Jakscha, J., Schaller, P., Nagel, G., Baumhoer, D., & Tzankov, A. (2025). Recurrent clonal radiotherapy-associated fibroepithelial polyp of the pharynx: Do low grade radiogenic stromal tumours exist? Case report.

Sobottka, B., Vetter, V., Banaei-Esfahani, A., Nowak, M., Lorch, A., Sirek, A., Mertz, K. D., Brunelli, M., Berthold, D., de Leval, L., et al. (2024). Immune phenotype-genotype associations in primary clear cell renal cell carcinoma and matched metastatic tissue.

Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Published on by Forensic Scientist

Dr. Fatemeh Shirani | Medicine and Health Sciences | Women Researcher Award

Endocrine and Metabolism Research Center | Iran

Dr. Fatemeh Shirani is a distinguished scholar in the field of Nutritional Sciences, renowned for her groundbreaking contributions to clinical nutrition, dietary epidemiology, and metabolic health. She has consistently advanced the understanding of how diet and nutrition influence chronic disease prevention and treatment, with a strong emphasis on obesity, diabetes, and cardiovascular disease. Through her innovative research and global collaborations, she has established herself as a thought leader whose work bridges scientific evidence with practical dietary strategies for public health. Currently serving at the Endocrine and Metabolism Research Center of Isfahan University of Medical Sciences, she has become a role model for women in science through her dedication, mentorship, and international engagement.

Professional Profile

Google Scholar

ORCID

Education

Dr. Fatemeh Shirani completed her academic journey with distinction in Nutritional Sciences, earning her foundational and advanced degrees from leading Iranian institutions. She further enriched her expertise through doctoral-level research at Ahvaz Jundishapur University of Medical Sciences, where she focused on the intricate links between nutrition and chronic diseases. Her academic training was complemented by international research at Victoria University in Melbourne, Australia, where she deepened her skills in nutritional biomedicine and clinical research methodologies. This comprehensive educational background provided her with a strong platform to integrate theoretical knowledge with practical application in clinical and population-based nutrition research.

Experience

Dr. Fatemeh Shirani has accumulated extensive experience across research, teaching, and scientific service. She has contributed to large-scale community-based projects, such as national nutrition surveys and heart health programs, aimed at improving public health outcomes through evidence-based interventions. As a dedicated educator, she has taught undergraduate and graduate students, instilling in them the principles of basic nutrition, clinical dietetics, and community health. Her expertise extends to laboratory techniques such as PCR and cell culture, which she has applied to translational nutrition studies. Beyond academia, she has actively participated as a reviewer for prestigious international journals, shaping the quality of published science in her field. Her professional journey reflects a balance of teaching, research, community service, and scientific leadership.

Research Interests

Dr. Fatemeh Shirani’s research interests lie at the intersection of nutrition, epidemiology, and chronic disease management. She is deeply invested in exploring obesity and weight-loss strategies, nutritional interventions for diabetes and metabolic disorders, and the role of diet in preventing cardiovascular disease. Her work also investigates the emerging field of “infectobesity,” examining the connections between viral infections and obesity. By employing systematic reviews, meta-analyses, and clinical trials, she provides high-quality evidence that informs dietary recommendations and policy guidelines. Her studies not only address the biological mechanisms of nutrition-related diseases but also emphasize the translation of findings into practical interventions for populations at risk.

Awards

Dr. Fatemeh Shirani has been widely recognized for her contributions to nutritional sciences, particularly her ability to merge clinical expertise with public health perspectives. Her nomination for the Women Researcher Award reflects her outstanding achievements in advancing women’s representation in scientific leadership and her sustained impact on global nutrition research. She has consistently demonstrated excellence through her publications, conference presentations, and active participation in national and international nutrition societies. This recognition highlights not only her scientific accomplishments but also her commitment to mentoring young researchers and fostering collaborative networks across borders.

Publication

Dr. Fatemeh Shirani has produced a rich body of work that has been widely cited in international literature. Selected publications include:

Title: Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases incidence: a systematic review and meta-analysis
Journal: Nutrition
Published on: 2013
Citation: 482

Title: The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta‐analysis of randomized controlled trials
Journal: Obesity Reviews
Published on: 2016
Citation: 308

Title: Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials
Journal: Nutrition
Published on: 2013
Citation: 288

Title: The role of magnesium in sleep health: a systematic review of available literature
Journal: Biological Trace Element Research
Published on: 2023
Citation: 104

Title: Is phase angle a valuable prognostic tool in cancer patients’ survival? A systematic review and meta-analysis of available literature
Journal: Clinical Nutrition
Published on: 2021
Citation: 98

Title: Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials
Journal: Diabetes Research and Clinical Practice
Published on: 2017
Citation: 95

Title: Effects of concentrated pomegranate juice on subclinical inflammation and cardiometabolic risk factors for type 2 diabetes: A quasi-experimental study
Journal: International Journal of Endocrinology and Metabolism
Published on: 2016
Citation: 55

Conclusion

In conclusion, Dr. Fatemeh Shirani stands as a leading figure in nutritional sciences whose contributions have advanced both research and practice in the prevention and management of chronic diseases. Her ability to translate complex scientific findings into practical dietary strategies has had a lasting impact on public health. With her strong publication record, global collaborations, and dedication to mentorship, she exemplifies the qualities of an outstanding woman researcher. Her nomination for the Women Researcher Award reflects not only her academic excellence but also her leadership, vision, and commitment to improving health outcomes through nutrition science.

Prabhat Singh | Pharmacology | Excellence in Research

Published on by Forensic Scientist

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

📚 Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.

Hasan Hallaçeli | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Hasan Hallaçeli | Medicine | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Hasan Hallaçeli is a distinguished Turkish physiotherapist and academician specializing in orthopedic rehabilitation. A 1989 graduate of Hacettepe University with a Ph.D. earned in 1996, he is currently serving at Hatay Mustafa Kemal University, Faculty of Medicine. With a visionary approach, he has pioneered the establishment of orthopedic physiotherapy departments in four university hospitals across Turkey. As an honorary member of the Turkish Orthopaedics and Traumatology Association, he has devoted his career to enhancing postoperative rehabilitation, especially for knee, shoulder, and elbow surgeries. Passionate about education and service, he has supervised 10 master’s theses and contributed to over 100 scientific outputs, while actively volunteering in combat sports and for children with disabilities.

Professional profile👤

Google Scholar

Scopus

Strengths for the Awards✨

  • Extensive Academic Background: Ph.D. in Physiotherapy (1996); graduated from Hacettepe University, a top institution in Turkey.

  • Institution Building: Established orthopaedic physiotherapy departments in four university hospitals across Turkey.

  • Research Contributions:

    • Over 100 scientific publications including:

      • 11 SCI-indexed journal articles

      • 19 international/national refereed journal papers

      • 19 book chapters

      • 55 conference presentations

  • Editorial Roles: Editor of three specialized books in orthopaedic physiotherapy.

  • Book Publications:

    • Ortopedik Fizyoterapi ve Rehabilitasyon (2021)

    • Ortopedik Fizyoterapi – Diz (2020)

    • Physiotherapy And Rehabilitation in Knee Joint Extensor Mechanism (2022)

🎓 Education

Dr. Hallaçeli graduated from Hacettepe University’s Faculty of Physiotherapy and Rehabilitation in 1989. He pursued his academic aspirations further and obtained a Ph.D. in 1996. His academic journey reflects a strong foundation in clinical expertise and theoretical rigor, setting the stage for his future innovations in orthopedic physiotherapy.

💼 Experience

Prof. Hallaçeli has held influential academic positions across Turkey, playing a key role in the foundation of orthopedic physiotherapy units in multiple universities. With vast clinical experience, he focuses on rehabilitation following orthopedic surgeries, especially in high-impact joints. His clinical skills, combined with over three decades of academic leadership, have significantly shaped the field in both practice and policy.

🔬 Research Interests On Medicine

His research interests center on orthopedic physiotherapy—particularly the rehabilitation of the shoulder, elbow, and knee—and extend into sports injuries in combat sports. Dr. Hallaçeli also conducts multidisciplinary studies on postural balance and fall risk among patients with knee osteoarthritis and post-prosthetic surgery. His work aims to improve patient safety and athletic performance through scientific insights.

🏆 Awards

Prof. Hallaçeli is recognized as an Honorary Member of the Turkish Orthopaedics and Traumatology Association for his notable contributions to the field. In addition to academic leadership, his dedication to community services—especially for disabled children and combat sports athletes—has further solidified his reputation as a compassionate and impactful professional.

📚 Publications

  • The effect of combined therapy (spa and physical therapy) on pain in various chronic diseases
    A Cimbiz, V Bayazit, H Hallaceli, U Cavlak
    📅 2005 | 📑 73 citations

  • Normal hip, knee and ankle range of motion in the Turkish population
    H Hallaceli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, T Parpucu, …
    📅 2014 | 📑 72 citations

  • Importance of anatomy education in physical therapy and rehabilitation in Turkey: A qualitative study
    F Duman, I Huzmeli, B Yucekaya, H Hallaceli, M Gunes
    📅 2017 | 📑 18 citations

  • Normal range of scapular elevation and depression in healthy subjects
    H Hallaceli, I Günal
    📅 2002 | 📑 13 citations

  • A new anchor augmentation technique with a cancellous screw in osteoporotic rotator cuff repair: an in vitro biomechanical study on sheep humerus specimens
    V Uruc, R Ozden, Y Dogramacı, A Kalacı, H Hallaceli, F Küçükdurmaz
    📅 2014 | 📑 12 citations

  • Goniometric Measurements of the Angular Values of the Joints in the Fore-and Hindlimbs of Kangal Dogs
    S Ates, C Hallaceli, H Hallaceli, I Kürtül
    📅 2011 | 📑 11 citations

  • Does scapular elevation accompany glenohumeral abduction in healthy subjects?
    H Hallaceli, M Manisali, I Gunal
    📅 2004 | 📑 11 citations

  • Türk toplumunda kalça diz ve ayak bileğinin normal eklem hareket açıklığı
    H Hallaçeli, V Uruç, HH Uysal, R Özden, Ç Hallaçeli, F Soyuer, …
    📅 2014 | 📑 10 citations

  • Injuries in wheelchair basketball players
    ED Huzmeli, N Katayifci, H Hallaceli
    📅 2017 | 📑 8 citations

  • A new clinical design measuring the vertical axial rotation through tibial shaft resulting from passive knee and subtalar joints rotation in healthy subjects: A reliability study
    A Cımbız, U Cavlak, M Sarı, H Hallaceli, F Beydemir
    📅 2006 | 📑 8 citations

🔚 Conclusion

In conclusion, Prof. Dr. Hasan Hallaçeli’s career embodies excellence in orthopedic physiotherapy, scholarly publishing, and community engagement. With over three decades of dedicated academic, clinical, and volunteer service, he continues to inspire through innovation and empathy. His interdisciplinary focus—bridging rehabilitation, sports, and education—makes him a deserving candidate for any prestigious recognition.

Zhengfeng Jia | Medicine | Excellence in Research

Published on by Forensic Scientist

Prof. Dr. Zhengfeng Jia | Medicine | Excellence in Research

Fourth medical PLA general hospital | China

Dr. Zhengfeng Jia is a researcher in orthopedic biomechanics, focusing on distal humerus fractures, musculoskeletal dynamics, and finite element analysis. Affiliated with the Chinese PLA General Hospital and the National Clinical Research Center for Orthopedics, his work bridges computational modeling and clinical applications to optimize fracture fixation and rehabilitation strategies.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Innovative Methodology

    • The study integrates musculoskeletal dynamics (AnyBody software) with finite element analysis (Abaqus) to simulate real-world biomechanical conditions, overcoming the limitations of traditional static models.

    • The AnyBody-Abaqus coupling technique provides dynamic loading conditions, capturing muscle forces and joint reactions during elbow flexion/extension, which is rare in orthopedic biomechanics research.

  2. Clinical Relevance

    • Addresses a critical gap in distal humerus fracture management by quantifying “safe activity windows” for postoperative rehabilitation (e.g., ≤80° flexion for parallel plates, ≤30° for vertical plates).

    • Findings directly inform surgical decisions (e.g., plate configuration) and rehabilitation protocols to reduce complications like non-union.

  3. Rigorous Validation

    • Validates muscle forces using electromyography (EMG) literature and mesh convergence studies to ensure computational accuracy (<5% error).

    • Anatomical accuracy is confirmed via statistical shape modeling (SSM) and iterative closest point (ICP) algorithms (<1.2 mm error).

  4. High-Impact Results

    • Demonstrates that parallel plates outperform vertical plates in maintaining interfragmentary motion (IFM) within the healing threshold (0.06–0.20 mm).

    • Identifies stress migration paths in the humerus, correlating with anatomical weak zones (e.g., lateral condyle).

  5. Interdisciplinary Approach

    • Combines orthopedic surgery, biomechanics, and computational modeling, aligning with the trend of “smart orthopedics.”

Education 🎓

  • PhD Candidate in Orthopedics, Graduate School of Medical School of Chinese PLA Hospital, Beijing (Current).

  • Research training in musculoskeletal dynamics, 3D modeling, and finite element analysis (FEA).

Experience 💼

  • Researcher at the Fourth Medical Center of Chinese PLA General Hospital, Beijing.

  • Specializes in digital orthopedic technologies, including AnyBody-Abaqus joint modeling and biomechanical simulations.

  • Collaborates on studies quantifying “safe activity windows” for postoperative rehabilitation.

Research Interests On Medicine 🔍

  • Biomechanics of distal humerus fractures.

  • Musculoskeletal dynamics and finite element analysis (FEA).

  • Optimization of internal fixation plates and rehabilitation protocols.

  • AI applications in orthopedic decision-making.

Awards & Nominations 🏆

  • National Clinical Research Center for Orthopedics Grant (2024) for data-driven ulnar prostheses research.

  • Ethical approval recipient (2024KY005-KS001) for studies on fracture healing biomechanics.

Publications 📚

  1. Jia, Z., Xu, C., Gao, W., et al. (2025). Evaluation of internal fixation stability of distal humerus C-type fractures based on musculoskeletal dynamics: Finite element analysis under dynamic loading. Journal of Orthopaedic Surgery and Research, *20*(475).

  2. Contributed to meta-analyses on continuous passive motion post-arthroplasty (J Orthop Surg Res, 2024).

Conclusion 🌟

Zhengfeng Jia’s multidisciplinary research quantifies biomechanical thresholds for fracture healing, emphasizing parallel plate configurations and 30–80° flexion safety windows. His integration of AnyBody-Abaqus modeling advances personalized rehabilitation strategies, with future aims to validate findings in clinical trials and AI-driven orthopedic solutions.

Rongrong Yang | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Rongrong Yang | Medicine | Best Researcher Award

Zhongnan Hospital of Wuhan University | China

Prof. Yang Rongrong, M.D., serves as a Chief Physician, Associate Professor, and Master’s Supervisor, with an esteemed career in infectious disease prevention, particularly in HIV/AIDS occupational exposure management. With numerous national and provincial research leadership roles and active involvement in academic and peer review, she stands out as a leading voice in public health research and medical education in China.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Distinguished Research Leadership:
    Dr. Yang has led multiple competitive and prestigious research projects, including funding from the National Natural Science Foundation of China, Hubei Provincial bodies, and Wuhan University. This reflects a high level of trust in her scientific capabilities and leadership.

  • High-impact Publications:
    With 52 professional papers, 29 of which are SCI-indexed, and a cumulative impact factor of 206.586, Dr. Yang demonstrates significant scholarly contribution in the field of infectious diseases. This publication record shows consistency, quality, and depth.

  • Expert Recognition and Peer Review Contributions:
    Her role as a peer reviewer for numerous high-impact SCI journals (e.g., iScience, Frontiers, PLOS ONE) and as a thesis review expert for the Ministry of Education highlights her academic reputation and recognition by the broader scientific community.

  • Public Health Relevance:
    Her focus on HIV/AIDS prevention and occupational exposure is of critical importance to public health. Her work bridges clinical medicine and public health, offering real-world impact.

  • Mentorship and Academic Service:
    As a Master’s supervisor and associate professor, Dr. Yang contributes significantly to academic training and capacity building in medical sciences.

🎓 Education

Dr. Yang holds a Doctor of Medicine degree and has advanced through the academic ranks, distinguished by her role as a Degree Thesis Review Expert for the Academic Degree Center of the Ministry of Education, reflecting her academic rigor and dedication to mentoring postgraduate students.

🧑‍🔬 Experience

Dr. Yang is a Medical Science Research Project Review Expert for Wuhan City, and actively serves as a peer reviewer for high-impact SCI journals including iScience, PLOS ONE, Frontiers in Public Health, and Risk Management and Healthcare Policy. Her influence in clinical medicine is matched by her engagement in policy and program-level evaluations across provincial and national platforms.

🔬 Research Interests On Medicine

Her primary research focus is the prevention and treatment of infectious diseases, with an emphasis on HIV/AIDS and occupational exposure. She contributes significantly to public health strategies through translational research, applying scientific findings to real-world clinical and preventative practices.

🏆 Awards & Recognitions

Dr. Yang has led several high-profile research projects:

  • National Natural Science Foundation of China (Grant No. 82003511)

  • Youth Talent Project, Hubei Provincial Health and Family Planning Commission (WJ2015Q0192)

  • Key Project, Hubei Provincial Center for Disease Control and Prevention

  • Independent Research Grant, Wuhan University
    These recognitions underscore her role as a Principal Investigator and emerging leader in public health innovation.

📚 Publications

Dr. Yang has authored 52 professional papers, with 29 SCI-indexed works contributing to a total impact factor of 206.586. Below are some of her notable publications with citation data:

  1. Yang, R. et al. (2023). “Evaluation of occupational exposure control in HIV-prone environments.” Frontiers in Public Health. Link – Cited by 12 articles

  2. Yang, R. et al. (2022). “Innovative HIV prevention strategies for healthcare workers.” PLOS ONE. Link – Cited by 20 articles

  3. Yang, R. et al. (2021). “Case report on pediatric HIV exposure.” Frontiers in Pediatrics. Link – Cited by 7 articles

  4. Yang, R. et al. (2020). “Public health surveillance and HIV: A real-time case study.” JMIR Public Health and Surveillance. Link – Cited by 15 articles

  5. Yang, R. et al. (2019). “Risk analysis of healthcare settings in HIV/AIDS exposure.” Risk Management and Healthcare Policy. Link – Cited by 18 articles

🔚 Conclusion

With a distinguished portfolio of clinical practice, academic service, and research leadership, Dr. Yang Rongrong has made a significant impact in infectious disease control and occupational health safety. Her contribution to medical science is not only academic but also societal, shaping public health policies and clinical standards in China and beyond.